| Names | |
|---|---|
| IUPAC name 7-Methylguanine | |
| Preferred IUPAC name 2-Amino-7-methyl-1,7-dihydro-6H-purin-6-one | |
| Other names N7-Methylguanine; Epiguanine | |
| Identifiers | |
3D model (JSmol) | |
| 174245 | |
| ChEBI | |
| ChemSpider | |
| ECHA InfoCard | 100.008.575 |
| EC Number |
|
| KEGG | |
PubChem CID | |
| UNII | |
CompTox Dashboard (EPA) | |
| |
| |
| Properties | |
| C6H7N5O | |
| Molar mass | 165.156 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
7-Methylguanine is a modified purine nucleobase. It is a methylated version of guanine. The 7-methylguanine nucleoside is called 7-methylguanosine. However, the free 7-methylguanine base is not involved in the synthesis of nucleotides and not incorporated directly into nucleic acids. [1] [2] 7-Methylguanine is a natural inhibitor of poly (ADP-ribose) polymerase (PARP) and tRNA guanine transglycosylase (TGT) - and thus may exert anticancer activity. [3] [4] [5] For example, it was demonstrated that 7-methylguanine could accelerate apoptotic death of BRCA1-deficient breast cancer cells induced by cisplatin and doxorubicin. [6]